These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6974064)

  • 41. Antigen-specific detection of soluble immune complexes in conglutinin-binding assays.
    D'Amelio R; Brighouse G; Barnet M; Lambert PH
    Clin Exp Immunol; 1981 Aug; 45(2):283-9. PubMed ID: 7318255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating immune complexes in Plasmodium knowlesi infected Kra, and merozoite vaccinated Rhesus monkeys.
    Shepherd PS; Burke P; Thomas A; Mitchell GH; Cohen S
    Clin Exp Immunol; 1982 May; 48(2):315-20. PubMed ID: 6980742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of a protein meal on three fluid-phase assays for circulating immune complexes.
    Elkon KB; Lanham JG; Dash AC; Hughes GR
    Clin Exp Immunol; 1981 Aug; 45(2):279-82. PubMed ID: 6976243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lysosomal enzyme release from polymorphonuclear leukocytes induced by immune complexes of IgM and of IgG.
    Lucisano YM; Mantovani B
    J Immunol; 1984 Apr; 132(4):2015-20. PubMed ID: 6699405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clearance pathways of soluble immune complexes in the pig. Insights into the adaptive nature of antigen clearance in humans.
    Davies KA; Chapman PT; Norsworthy PJ; Jamar F; Athanassiou P; Keelan ET; Harrison AA; Binns RM; Haskard DO; Walport MJ
    J Immunol; 1995 Dec; 155(12):5760-8. PubMed ID: 7499864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo responses to inhaled proteins. III. Inhibition of experimental immune complex pneumonitis after suppression of peripheral blood lymphocytes.
    Shenker BJ; Willoughby WF; Hollingdale MR; Mann TN
    J Immunol; 1980 Apr; 124(4):1763-72. PubMed ID: 6245129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of immune complexes in serum of dogs with neoplastic disease by solid-phase C1q binding, using an enzyme-linked immunosorbent assay.
    DeBoer DJ; Madewell BR
    Am J Vet Res; 1983 Sep; 44(9):1710-3. PubMed ID: 6605101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Requirements for the binding of human plasma fibronectin to the C1q subunit of the first component of complement.
    Sorvillo J; Gigli I; Pearlstein E
    J Immunol; 1983 Sep; 131(3):1400-4. PubMed ID: 6309962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cartilage proteoglycan interactions with C1q and the localization of aggregated IgG complexes in cartilage.
    Sparks K; Goetinck P; Ballow M
    Prog Clin Biol Res; 1982; 110 Pt B():113-23. PubMed ID: 6984760
    [No Abstract]   [Full Text] [Related]  

  • 50. Complement depletion accelerates the clearance of immune complexes from the circulation of primates.
    Waxman FJ; Hebert LA; Cornacoff JB; VanAman ME; Smead WL; Kraut EH; Birmingham DJ; Taguiam JM
    J Clin Invest; 1984 Oct; 74(4):1329-40. PubMed ID: 6480828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation.
    Mannik M; Arend MP; Hall AP; Gilliland BC
    J Exp Med; 1971 Apr; 133(4):713-39. PubMed ID: 5547056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.
    Davies KA; Peters AM; Beynon HL; Walport MJ
    J Clin Invest; 1992 Nov; 90(5):2075-83. PubMed ID: 1430231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The rapidly changing nature of acute immune complex disease.
    Griswold WR; Brams M; McNeal R
    J Lab Clin Med; 1980 Jul; 96(1):57-66. PubMed ID: 6446589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on rheumatoid factor: I. The effect of rheumatoid factor on the clearance of preformed immune complexes in mice.
    Hogben DN; Devey ME
    Clin Exp Immunol; 1986 Dec; 66(3):648-53. PubMed ID: 3568452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies in cobra venom factor treated rats of antibody coated erythrocyte clearance by the spleen: differential influence of red blood cell antigen number on the inhibitory effects of immune complexes on Fc dependent clearance.
    Yousaf N; Howard JC; Williams BD
    Clin Exp Immunol; 1986 Dec; 66(3):654-60. PubMed ID: 3568453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cooperative binding of a complement component to antigen-antibody complexes. III. Complexes containing IgM antibodies.
    Kuo CY; Thompson JJ; Hoffmann LG
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):151-66. PubMed ID: 960974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Demonstration of hepatic Fc receptor function in vivo.
    Yousaf N; Howard JC; Williams BD
    Clin Exp Immunol; 1989 Nov; 78(2):278-84. PubMed ID: 12412762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity of antigen complexed with antibody. I. Role of different isotypes.
    Farkas AI; Medgyesi GA; Füst G; Miklós K; Gergely J
    Immunology; 1982 Mar; 45(3):483-92. PubMed ID: 7061107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.